Mega Lifesciences Public Company Limited

SET:MEGA Stock Report

Market Cap: ฿29.4b

Mega Lifesciences Past Earnings Performance

Past criteria checks 2/6

Mega Lifesciences has been growing earnings at an average annual rate of 11.3%, while the Pharmaceuticals industry saw earnings growing at 9.3% annually. Revenues have been growing at an average rate of 7.6% per year. Mega Lifesciences's return on equity is 20%, and it has net margins of 11.6%.

Key information

11.3%

Earnings growth rate

11.2%

EPS growth rate

Pharmaceuticals Industry Growth12.4%
Revenue growth rate7.6%
Return on equity20.0%
Net Margin11.6%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Mega Lifesciences makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SET:MEGA Revenue, expenses and earnings (THB Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2415,8821,8464,4100
30 Jun 2415,6851,9994,3310
31 Mar 2415,7182,0174,2300
31 Dec 2315,7161,9934,1910
30 Sep 2315,4421,9194,2780
30 Jun 2315,6932,0424,3520
31 Mar 2315,6342,0814,3980
31 Dec 2215,7272,2424,3590
30 Sep 2215,1162,3384,0680
30 Jun 2215,0612,2924,0540
31 Mar 2214,7242,2273,9240
31 Dec 2114,1721,9473,7690
30 Sep 2114,3951,8783,7670
30 Jun 2113,7751,6073,5380
31 Mar 2112,8091,4063,3310
31 Dec 2012,6131,3933,2880
30 Sep 2012,1681,3483,1690
30 Jun 2011,6421,2883,1370
31 Mar 2011,6551,2053,1950
31 Dec 1911,1641,1393,1760
30 Sep 1910,9501,1633,1980
30 Jun 1910,7121,1363,1530
31 Mar 1910,5691,2033,1130
31 Dec 1810,2841,2063,0520
30 Sep 1810,1471,1833,0410
30 Jun 189,9371,1753,0100
31 Mar 189,8291,1782,9880
31 Dec 179,6241,1132,9650
30 Sep 179,5141,0232,9280
30 Jun 179,2829452,8690
31 Mar 178,9688732,7660
31 Dec 168,8287952,6740
30 Sep 168,5147712,6030
30 Jun 168,2267562,6580
31 Mar 168,1157032,7140
31 Dec 157,9666962,7180
30 Sep 157,7756752,6680
30 Jun 157,8626342,5800
31 Mar 157,8515982,4860
31 Dec 147,7495482,4710
30 Sep 147,6204742,4540
30 Jun 147,4225162,3620
31 Mar 147,2265672,3040
31 Dec 137,0556242,2360

Quality Earnings: MEGA has high quality earnings.

Growing Profit Margin: MEGA's current net profit margins (11.6%) are lower than last year (12.4%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: MEGA's earnings have grown by 11.3% per year over the past 5 years.

Accelerating Growth: MEGA's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: MEGA had negative earnings growth (-3.8%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (6.1%).


Return on Equity

High ROE: MEGA's Return on Equity (20%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 09:13
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Mega Lifesciences Public Company Limited is covered by 19 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yuwanee PrommapornBNP Paribas Securities (Asia)
Graham PriceCGS International
null nullDBS Bank Ltd